[Helicobacter pylori infection: relationships between gastritis and clinical symptomatology].
Bruley Des Varannes
S
S
Clinique des Maladies de l'Appareil Digestif, CHU G.-et-R.-Laennec, Nantes.
Scarpignato
C
C
D000863:Antacids / Q000627:therapeutic use; D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D004359:Drug Therapy, Combination; D004415:Dyspepsia / Q000453:epidemiology* / Q000209:etiology; D005757:Gastritis, Atrophic / Q000150:complications / Q000188:drug therapy / Q000453:epidemiology* / Q000382:microbiology; D016481:Helicobacter Infections / Q000150:complications / Q000188:drug therapy / Q000453:epidemiology* / Q000382:microbiology; D016480:Helicobacter pylori / Q000302:isolation & purification*; D006801:Humans; D015995:Prevalence
D000863:Antacids; D000900:Anti-Bacterial Agents
Infection à Helicobacter pylori: relations entre gastrite et symptomatologie clinique.